Poor Survival Rate in Patients with Postoperative Intra-abdominal Infectious Complications Following Curative Gastrectomy for Gastric Cancer
Overview
Affiliations
Background: The impact of postoperative complications on recurrence rate and long-term outcome has been reported in patients with colorectal and esophageal cancer, but not in patients with gastric cancer. This study evaluated the impact of postoperative intra-abdominal infectious complications on long-term survival following curative gastrectomy.
Methods: This study included 765 patients who underwent curative gastrectomy for gastric cancer between 2002 and 2006. Patients were divided into 2 groups: with (C-group, n = 81) or without (NC-group, n = 684) intra-abdominal infectious complications. Survival curves were compared between the groups, and multivariate analysis was conducted to identify independent prognostic factors.
Results: Male patients were dominant, and total gastrectomy was frequently performed in the C-group. The pathological stage was more advanced and D2 lymph node dissection and splenectomy were preferred in the C-group. The 5-year overall survival (OS) rate was better in the NC-group (86.8 %) than in the C-group (66.4 %; P < .001). The 5-year relapse-free survival (RFS) rate was also better in the NC-group (84.5 %) than in the C-group (64.9 %; P < .001). This trend was still observed in stage II and III patients after stratification by pathological stage. Multivariate analysis identified intra-abdominal infectious complication as an independent prognostic factor for OS (hazard ratio, 2.448; 95 % confidence interval [95 % CI], 1.475-4.060) and RFS (hazard ratio, 2.219; 95 % CI, 1.330-3.409) in patients with advanced disease.
Conclusions: Postoperative intra-abdominal infectious complications adversely affect OS and RFS. Meticulous surgery is needed to decrease the complication rate and improve the long-term outcome of patients following curative gastrectomy.
Usefulness of Serum Biomarkers in Predicting Anastomotic Leakage After Gastrectomy.
Ramos D, Gallego-Colon E, Minguez J, Bodega I, Priego P, Garcia-Moreno F Cancers (Basel). 2025; 17(1.
PMID: 39796753 PMC: 11720279. DOI: 10.3390/cancers17010125.
Christodoulidis G, Voutyras A, Fotakopoulos G, Koumarelas K, Georgakopoulou V, Kouliou M Cureus. 2024; 16(10):e71516.
PMID: 39553069 PMC: 11563776. DOI: 10.7759/cureus.71516.
Impact of infectious complications after gastrectomy on non‑gastric cancer‑related deaths.
Nakashima C, Iida M, Nishiyama M, Watanabe Y, Shindo Y, Tokumitsu Y Oncol Lett. 2024; 28(6):562.
PMID: 39385950 PMC: 11462511. DOI: 10.3892/ol.2024.14695.
Cai W, Zeng X, Huang Y, Chen W, Chen X, Xie X Front Oncol. 2024; 14:1416888.
PMID: 39234398 PMC: 11371684. DOI: 10.3389/fonc.2024.1416888.
Toji Y, Takeuchi S, Ebihara Y, Kurashima Y, Harada K, Hayashi M Surg Case Rep. 2024; 10(1):200.
PMID: 39192090 PMC: 11349963. DOI: 10.1186/s40792-024-02001-w.